RUBIN’S REFLECTIONS

Follow on Twitter @IBDMD

Message to Dr. Rubin’s Patients Related to COVID-19 Boosters

Aug 13, 2021

Dear Friends and Patients, I hope this message finds you well. Please excuse the group nature of this message, but I did want to reach out with the latest update about COVID-19, and vaccinations. If you want to skip right to the booster info, scroll down to #5 below....

Tweetorial to Provide Updates on COVID-19 for Patients with IBD

Jul 30, 2021

View Twitter Thread To watch me deliver the full lecture and view the presentation, click here. I recently gave a lecture about COVID-19 and vaccination with specific information for patients with IBD. This lecture was recorded on July 21st, before the CDC issued...

Tweetorial to Clarify the NYT Article From 15 April and Further Explain/Clarify the UK CLARITY IBD Study

Apr 18, 2021

Tweetorial to Clarify the NYT Article From 15 April and Further Explain/Clarify the UK CLARITY IBD Study David T. Rubin View Twitter Thread I've previously commented about the CLARITY IBD Study (Kennedy, et al). paper in this forum, but it bears repeating and further...

SARS Vaccine and IBD Tweetorial Summary from December 1

Dec 5, 2020

SARS Vaccine and IBD Tweetorial Summary from December 1 David T. Rubin View Twitter Thread Here are my thoughts and a few updates about SARS-CoV-2 vaccines, and also about important implications for our IBD patients. Development of multiple SARS-CoV-2 vaccines in the...

Approach to Management and Interpretation of Testing Results in Patients with IBD, with Particular Attention to Restarting Therapy

Apr 21, 2020

By David T. Rubin, MD, Professor of Medicine, University of Chicago Medicine As testing for SARS-CoV-2 is expanded and serologic antibody testing becomes available, we are faced with a number of different clinical scenarios. I have outlined the different situations...

Three waves of Illness from the COVID-19 Pandemic

Apr 1, 2020

By David T. Rubin, MD, Professor of Medicine, University of Chicago Medicine I've been thinking about what comes next, and how can we get ahead of this, and propose the following for consideration. I believe that there will be three waves of illness from the...

“Monitor Histologically Normalized UC for Relapse” on MedPage Today

by dtrubin | June 27, 2019 | histology, In the Press, normalization, UC | 0 Comments

"These patients require ongoing monitoring and follow-up," the study's first author, Amanda M. Israel, MD, also of the University of Chicago Medicine, told MedPage Today. Our graduating Advanced IBD Fellow, Amanda Israel, was published her findings on the “Follow-Up...

A Cure for Crohn’s: How Close Is It?

by David Rubin | October 20, 2020 | In the Press | 0 Comments

Dr. David Rubin discusses advancements in Crohn's disease treatment. "And while there isn’t a cure for Crohn’s yet, we’ve come a long way in how we assess and treat it. Treatment used to involve trying a new medicine or therapy and waiting to see if it made you feel...

Trial by Data: Chronic Disease & Data

by dtrubin | May 15, 2018 | Data, In the Press, monitoring | 0 Comments

Listen to Dr. Rubin featured on a podcast by Litmus Health, Trial by Data, exploring data-driven technologies and strategies shaping the future of clinical trials. Dr. Rubin talks about the importance of optimism in patient care and his own clinical trial using...

Special Edition VGR: COVID-19 Vaccine Update

by David Rubin | April 2, 2021 | In the Press | 0 Comments

Click here to watch Dr. David Rubin and his colleagues explain the data behind the various vaccines, clinical recommendations, allergy and safety recommendation, and describe COVID-19 vaccine special issues in underrepresented minorities.

What Can We Do To Prevent COVID-19?

by tinar | June 7, 2021 | In the Press | 0 Comments

Click here for the full video discussing the use of COVID-19 vaccines to prevent COVID-19 infections in patients with inflammatory bowel disease.

Dr. David T. Rubin Hosts Pearls from the Pros on IBD Management

by David Rubin | March 1, 2022 | In the Press | 0 Comments

Dr. Rubin hosted four episodes of MedEd Talks Gastroenterology's Pearls from the Pros on IBD Management, featuring several colleagues to discuss best practices in using different classes of IBD therapies. Dr. Rubin spoke with Dr. Bruce Sands, Gastroenterologist and...

UPDATE ON IBD AND COVID FOR PATIENTS

by David Rubin | September 9, 2020 | In the Press, Uncategorized | 0 Comments

Listen to Dr. David Rubin, Professor of Medicine at the University of Chicago Medicine and Chief of the Section of Gastroenterology, Hepatology, and Nutrition, as he provides an update on SARS-CoV2, COVID-19, and what we know and how we can get through this together....

Definition of “healing” and sustained remission

by dtrubin | December 6, 2019 | histology, normalization, Rubin's Reflections | 0 Comments

The FDA and others have been interested in the role of histology for assessing “deeper” levels of disease control, with the premise that biopsy may reflect the state of the disease more accurately and perhaps more objectively than endoscopy, and certainly more than...

G&E News Expert Picks by Dr. Rubin: Best of ECCO 2019

by dtrubin | September 18, 2019 | In the Press | 0 Comments

'In this installment of “Expert Picks,” David Rubin, MD, the Joseph B. Kirsner Professor of Medicine; the chief of the Section of Gastroenterology, Hepatology, and Nutrition; and a co-director of the Digestive Diseases Center at the University of Chicago Medicine and...

How to identify, manage patients with high-risk ulcerative colitis

by dtrubin | November 5, 2019 | In the Press, Presentations, UC | 0 Comments

Dr. Rubin discusses his presentation at ACG 2019 in San Antonio on identifying and managing patients with high-risk ulcerative colitis with Healio Gastroenterology. “The importance of knowing who is high risk has to do with your choices of treatment and your...